WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005105083) COMBINATION THERAPY COMPRISING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/105083    International Application No.:    PCT/US2005/012724
Publication Date: 10.11.2005 International Filing Date: 14.04.2005
Chapter 2 Demand Filed:    15.02.2006    
IPC:
A61K 31/437 (2006.01), A61K 31/522 (2006.01), A61K 31/585 (2006.01), A61K 45/06 (2006.01)
Applicants: NOVACARDIA, INC. [US/US]; 12651 High Bluff Drive, Suite 200, San Diego, California 92130 (US) (For All Designated States Except US).
OTSUKI, Lauren [US/US]; (US) (For US Only).
WIDDER, Kenneth [US/US]; (US) (For US Only).
DITTRICH, Howard C. [US/US]; (US) (For US Only)
Inventors: OTSUKI, Lauren; (US).
WIDDER, Kenneth; (US).
DITTRICH, Howard C.; (US)
Agent: MALLON, Joseph J.; 2040 Main Street, 14th Floor, Irvine, California 92614 (US).
HART, Daniel; KNOBBE, MARTENS, OLSON & BEAR, LLP, 2040 Main Street, 14th Floor, Irvine, CA 92614 (US)
Priority Data:
60/563,166 16.04.2004 US
Title (EN) COMBINATION THERAPY COMPRISING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR
(FR) THERAPIE COMBINEE IMPLIQUANT UN ANTAGONISTE DE RECEPTEUR D'ADENOSINE A1 ET UN INHIBITEUR D'ALDOSTERONE
Abstract: front page image
(EN)Pharmaceutical compositions comprising an aldosterone inhibitor and an adenosine A1 receptor antagonist (AA1RA) and methods of treating cardiovascular disease comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient are disclosed.
(FR)La présente invention concerne des compositions pharmaceutiques comprenant un inhibiteur d'aldostérone et un antagoniste de récepteur d'adénosine A1 (AA1RA), ainsi que des procédés pour traiter des maladies cardio-vasculaires, qui consistent à identifier un patient qui a besoin d'un tel traitement, puis à administrer à ce patient une composition pharmaceutique telle que décrite.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)